Search research articles
Contact Us
Filters
Showing results (121-130 of 136) with videos related to
Page
of 14
Sort By:
Cancer Research
|
February 17, 2016
Myeloid-Derived Suppressor Cells Express Bruton's Tyrosine Kinase and Can Be Depleted in Tumor-Bearing Hosts by Ibrutinib Treatment
Andrew Stiff, Prashant Trikha, Robert Wesolowski, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
January 25, 2018
Nitric Oxide Production by Myeloid-Derived Suppressor Cells Plays a Role in Impairing Fc Receptor-Mediated Natural Killer Cell Function
Andrew Stiff, Prashant Trikha, Bethany Mundy-Bosse, et al.
Breast Cancer Research and Treatment
|
December 7, 2024
Phase II study of MEK inhibitor trametinib alone and in combination with AKT inhibitor GSK2141795/uprosertib in patients with metastatic triple negative breast cancer
Vishnu Prasath, Hinda Boutrid, Robert Wesolowski, et al.
Cancers
|
September 9, 2023
Depression, Inflammation, and Intestinal Permeability: Associations with Subjective and Objective Cognitive Functioning throughout Breast Cancer Survivorship
Annelise A Madison, Rebecca Andridge, Anthony H Kantaras, et al.
BMC Cancer
|
May 8, 2020
Metastatic breast cancer patient perceptions of somatic tumor genomic testing
Elizabeth J Adams, Sarah Asad, Raquel Reinbolt, et al.
JCO Precision Oncology
|
September 14, 2020
Prospective Decision Analysis Study of Clinical Genomic Testing in Metastatic Breast Cancer: Impact on Outcomes and Patient Perceptions
Daniel G Stover, Raquel E Reinbolt, Elizabeth J Adams, et al.
JAMA
|
May 24, 2022
Effect of Metformin vs Placebo on Invasive Disease-Free Survival in Patients With Breast Cancer: The MA.32 Randomized Clinical Trial
Pamela J Goodwin, Bingshu E Chen, Karen A Gelmon, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 9, 2026
VIKTORIA-1 Trial of Gedatolisib Plus Fulvestrant With or Without Palbociclib in Hormone Receptor-Positive/HER2-/PIK3CA Wild-Type Advanced Breast Cancer
Sara A Hurvitz, Rachel M Layman, Giuseppe Curigliano, et al.
The Journal of Clinical Investigation
|
August 5, 2025
BRD4 inhibition leads to MDSC apoptosis and enhances checkpoint blockade therapy
Himanshu Savardekar, Andrew Stiff, Alvin Liu, et al.
The Oncologist
|
May 27, 2020
Phase I Study of Veliparib on an Intermittent and Continuous Schedule in Combination with Carboplatin in Metastatic Breast Cancer: A Safety and [18F]-Fluorothymidine Positron Emission Tomography Biomarker Study
Robert Wesolowski, Daniel G Stover, Maryam B Lustberg, et al.
Page
of 14
Search research articles
Search
Showing results (121-130 of 136) with videos related to
Sort By:
Page
of 14
Cancer Research
|
February 17, 2016
Myeloid-Derived Suppressor Cells Express Bruton's Tyrosine Kinase and Can Be Depleted in Tumor-Bearing Hosts by Ibrutinib Treatment
Andrew Stiff, Prashant Trikha, Robert Wesolowski, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
January 25, 2018
Nitric Oxide Production by Myeloid-Derived Suppressor Cells Plays a Role in Impairing Fc Receptor-Mediated Natural Killer Cell Function
Andrew Stiff, Prashant Trikha, Bethany Mundy-Bosse, et al.
Breast Cancer Research and Treatment
|
December 7, 2024
Phase II study of MEK inhibitor trametinib alone and in combination with AKT inhibitor GSK2141795/uprosertib in patients with metastatic triple negative breast cancer
Vishnu Prasath, Hinda Boutrid, Robert Wesolowski, et al.
Cancers
|
September 9, 2023
Depression, Inflammation, and Intestinal Permeability: Associations with Subjective and Objective Cognitive Functioning throughout Breast Cancer Survivorship
Annelise A Madison, Rebecca Andridge, Anthony H Kantaras, et al.
BMC Cancer
|
May 8, 2020
Metastatic breast cancer patient perceptions of somatic tumor genomic testing
Elizabeth J Adams, Sarah Asad, Raquel Reinbolt, et al.
JCO Precision Oncology
|
September 14, 2020
Prospective Decision Analysis Study of Clinical Genomic Testing in Metastatic Breast Cancer: Impact on Outcomes and Patient Perceptions
Daniel G Stover, Raquel E Reinbolt, Elizabeth J Adams, et al.
JAMA
|
May 24, 2022
Effect of Metformin vs Placebo on Invasive Disease-Free Survival in Patients With Breast Cancer: The MA.32 Randomized Clinical Trial
Pamela J Goodwin, Bingshu E Chen, Karen A Gelmon, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 9, 2026
VIKTORIA-1 Trial of Gedatolisib Plus Fulvestrant With or Without Palbociclib in Hormone Receptor-Positive/HER2-/PIK3CA Wild-Type Advanced Breast Cancer
Sara A Hurvitz, Rachel M Layman, Giuseppe Curigliano, et al.
The Journal of Clinical Investigation
|
August 5, 2025
BRD4 inhibition leads to MDSC apoptosis and enhances checkpoint blockade therapy
Himanshu Savardekar, Andrew Stiff, Alvin Liu, et al.
The Oncologist
|
May 27, 2020
Phase I Study of Veliparib on an Intermittent and Continuous Schedule in Combination with Carboplatin in Metastatic Breast Cancer: A Safety and [18F]-Fluorothymidine Positron Emission Tomography Biomarker Study
Robert Wesolowski, Daniel G Stover, Maryam B Lustberg, et al.
Page
of 14